Custom Recombinant Protein Production Services Market

Custom Recombinant Protein Production Services Market, By Expression System (Mammalian, Bacteria, Insect, Yeast, and Others), By End User (Research Institutes, Biotechnology and Pharmaceutical Companies, Contract Research Organizations and Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Recombinant proteins have a wide range of applications in biotechnology, research, and medicine. Custom recombinant protein production is one of the efficient techniques used in the life sciences sector that plays a major role in advanced healthcare. Recombinant proteins are developed by manipulating proteins using certain techniques. Genes are then used to encode these recombinant proteins, which are then produced in large quantities and used to make therapeutic and commercial products. Increasing government initiatives and funding in the field of life sciences is expected to boost growth of the market.

Many recombinant proteins require and provide post-translational modifications such as glycosylation, which are only available in eukaryotic, yeast, mammalian, and insect cell culture systems. HEK293-derived cell lines are used for transient protein production. Currently, most recombinant therapeutic proteins are produced in mammalian cells due to their ability to produce high-quality proteins similar in nature. In addition, many approved recombinant therapeutic proteins have been produced in E. coli due to well-characterized genetics, rapid growth, and high-yield production.

Market Dynamics

The increasing adoption of inorganic growth strategies such as acquisitions by the key players is expected to drive segment growth over the forecast period. For instance, in July 2021, Atlas Antibodies, a manufacturer of highly validated primary antibodies, acquired Evitria, a developer of transient recombinant antibody expression in Chinese hamster ovary (CHO) cells. CHO cells are the preferred expression system for recombinant therapeutic protein (RTP) production. The acquisition will combine the antibody solutions of both companies and expand their businesses.

Key features of the study:

• This report provides an in-depth analysis of the global custom recombinant protein production services market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global custom recombinant protein production services market based on the following parameters– company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include GenScript Biotech Corporation, SignalChem Biotech Inc., Crown Bioscience, Inc., BPS Bioscience Inc., Novoprotein, Applied Biological Materials (abm) Inc., Eurofins Pharma Discovery Services, Abgent (WuXi AppTec Company), OriGene Technologies, Inc., Kempbio, Inc., Trenzyme GmbH, Sino Biological Inc., Aragen Bioscience, a GVKBIO Company, LakePharma, Inc., , Proteos Inc., Icosagen AS, Novus Biological LLC, Proteogenix, Premas Biotech, ATUM, and Aldevron
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global custom recombinant protein production services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global custom recombinant protein production services market.

Custom Recombinant Protein Production Services Market Detailed Segmentation:

• By Expression System:
• Mammalian
• Bacteria
• Insect
• Yeast
• Others
• By End User :
• Research Institutes
• Biotechnology and Pharmaceutical Companies
• Contract Research Organizations
• Others
• By Region:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa
• Company Profiles
• GenScript Biotech Corporation
• SignalChem Biotech Inc.
• Crown Bioscience, Inc.
• BPS Bioscience Inc.
• Novoprotein
• Applied Biological Materials (abm) Inc.
• Eurofins Pharma Discovery Services
• Abgent (WuXi AppTec Company)
• OriGene Technologies, Inc.
• Kempbio, Inc.
• Trenzyme GmbH
• Sino Biological Inc.
• Aragen Bioscience, a GVKBIO Company
• LakePharma, Inc.,
• Proteos Inc.
• Icosagen AS
• Novus Biological LLC
• Proteogenix
• Premas Biotech
• ATUM
• Aldevron